IJ

IC Jan

Managing Director at Taiwan Global Angels

Berkeley, California

Overview

Work Experience

  • Founder & Managing Director

    2022 - Current

    Taiwan Global Angels (TGA) is a global network of seasoned angel investors primarily based in the US and Taiwan. Typical syndicated investment: $200k to $3m per SPV in Seed to Series B startups. Our members are domain experts in healthcare, hardware, manufacturing, finance, and investments, and many of our members also belong to other angel groups. In our first two years of operation, we did 12M USD investment in the US since April 2022. Investments: - Botrista (Series B Co-Lead & Series C) - Serinus Labs (Seed) - CapsoVision (Growth) - Vocxi (Seed) - Figur8 (Series A-1) - E14 Fund III - Goodfin Fund - Aulea Medical (Series A Lead)

  • Advisor

    2022

  • Mentor

    2020 - 2022

    provide startup founders with pro bono mentorship, guidance, and one-on-one help in order to facilitate an accelerated and successful launch in biomedical and digital healthcare fields

  • Senior Advisor to the Dean

    2021

    As the co-founder and a startup mentor, I co-proposed and joined the workforce of the "Taiwan – Berkeley Health Innovation Accelerator" to support an annual cohort of startups from Taiwan who are seeking to bring their health innovations to the U.S. market. The program has been sponsored by the Nation Development Council in Taiwan since September 2021. https://publichealth.berkeley.edu/people/i-chien-jan/

  • Visiting Scholar

    2021 - 2021

    Continuing my visiting scholarship at Cal since 2020, I start to co-work with Berkeley School of Public Health in 2021 for "Taiwan Silicon Valley Health Innovation Accelerator".

  • Investor

    2023

    FIGUR8 is the market leader for standardizing musculoskeletal (MSK) health and injury recovery data. Through its innovative bioMotion Assessment Platform (bMAP), FIGUR8 empowers individuals to monitor and optimize their injury recovery, physical performance and overall health, while also enabling providers, patients and payers to access valuable data for advanced insights, better recovery and more personalized care.

  • Investor

    2023

    Vocxi Health commercializes a patented smart mask that measures disease in a minute of breathing.

  • Investor - Board Director

    2022

    Botrista is a robotics company based in San Francisco. They provide an end to end beverage solution to F&B retail chains. They have the capability to automate drink menus and pour an array of drinks including delicious and high profitable non-alcoholic mixed beverages. The Robot Barista increases drink selection, quality, and consistency whilereducing labor. It can also be modified to mix premium cocktails.

  • Board Member

    2022

    Being invited to join the Board Member of Innovation to Industry (i2i), the largest innovation and incubation service company in Taiwan to help international collaboration and startup ecosystem connections.

  • Chief Strategy Officer

    2021

    As the CSO of HKBio, I am in charge of corporate development and strategic investment of HuKui Bio and business development in the US. Hukui Bio is a one-stop shop for medical innovations, providing the best quality services such as contract designing, prototype development, small and large scale production, clinical trials, market launch clearance and certifications, and sales & distribution channels. Leveraging the global locations across the US, China, and Taiwan, Hukui Bio can serve our customers across most of the time zones very efficiently.

  • Strategic Advisor and Angel Investor

    2016

    I am the fist angel investor and also a strategic advisor of Blueseeds, an online marketplace that sells natural products for sustainable environment since 2016. At Blueseeds, we commit to produce natural essential oils and toiletry products without any artificial chemicals ingredients, aiming to deliver exceptional natural aroma experiences while contributing to environmental and social benefits. https://blueseeds.com/

Relevant Websites